An Illinois woman has filed a product liability lawsuit alleging that Xarelto (rivaroxaban), a drug designed to prevent strokes, has created an inability for her blood to clot in a timely manner. The plaintiff accuses drugmakers Janssen Pharmaceuticals and Bayer Healthcare of neglecting to investigate Xarelto before bringing it to market, and for failing to adequately warn of its potential health risks.
Free Confidential Case Evaluation: If you or a loved one was injured by Xarelto, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturers and we can help.
Update: Xarelto Bleeding Lawsuit Filed by 10 People in St. Clair County Court
September 6, 2016 – A group of 10 people who claim Xarelto caused severe bleeding have filed a lawsuit (case number 15-L670) against Bayer and Janssen Pharmaceuticals. Plaintiffs have charged the defendants with 9 counts of misconduct ranging from fraud to wrongful death for failing to warn about the potential health risks of Xarelto.
What’s the Problem?
The lawsuit, which was filed on behalf of Sonja Lemoins in St. Clair County Court on Jan. 22, alleges that Bayer and Janssen began selling Xarelto in 2011 after conducting a series of pre-approval clinical trials. During the trials, the companies discovered that Xarelto increased bleeding in certain parts of the body in some users, according to the complaint.
“Defendants use the results of the Rocket AF study, the Record studies, and the Einstein studies to promote Xarelto in their promotional materials, including the Xarelto website, which tout the positive results of those studies,” the lawsuit says. “However, defendants’ promotional materials fail to similarly highlight the increased risk of gastrointestinal bleeding and bleeding that required transfusion among other serious bleeding concerns.”
Bayer and Janssen spent at least $11 million marketing Xarelto in 2011 alone, resulting in approximately $582 million in sales, according to the lawsuit. However, the companies allegedly overstated the drug’s effectiveness and failed to warn of its anti-coagulation effects.
In 2012, there were 2,081 serious adverse events associated with Xarelto, 151 of which resulted in death, according to the complaint. Lemoins, in particular, claims to have suffered severe personal injuries including physical pain and mental anguish, diminished quality of life, and incurred medical costs and lost earnings, according to the lawsuit. The plaintiff is seeking more than $4.35 million in compensation for strict product liability, intentional infliction of emotional distress, negligent infliction of emotional distress, common law fraud, negligence, negligent misrepresentation and fraudulent misrepresentation.
Do I Have a Xarelto Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Xarelto lawsuits. We are handling individual litigation nationwide and currently accepting new Xarelto bleeding cases in all 50 states.
Free Case Evaluation: If you or a loved one has been injured by Xarelto, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.